Mohammad Krayem
12PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Jul 27, 2024
Correction: Krayem et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance. <i>Cancers</i> 2020, <i>12</i>, 512.Mohammad Krayem, Philippe Aftimos, Ahmad Najem
|Dec 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093.Mohammad Krayem, Malak Sabbah, Ahmad Najem
|Jul 29, 2023
Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies.Ahmad Najem, Mohammad Krayem, Serena Sabbah
|Nov 26, 2022
Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance.Pashalina Kehagias, Nadège Kindt, Mohammad Krayem
|Apr 23, 2022
The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease.Hamza AlGhamdi, Jennifer Dhont, Mohammad Krayem
|Apr 12, 2022
Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.Ahmad Najem, Laura Soumoy, Malak Sabbah
Pageof 2
Frequent Collaborators
8 joint publications
Ahmad Najem
5 joint publications
Ahmad Awada
3 joint publications
Dirk Van Gestel
3 joint publications
Laura Soumoy
2 joint publications
Riet Hilhorst
2 joint publications
An Wouters
2 joint publications
Filip Lardon
1 joint publications
Corentin Schepkens
1 joint publications
Bertrand Blankert
1 joint publications
Hamza AlGhamdi
